188 related articles for article (PubMed ID: 35778964)
1. BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma.
Zhu Q; Gu X; Wei W; Wu Z; Gong F; Dong X
Cancer Med; 2023 Jan; 12(2):1572-1587. PubMed ID: 35778964
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
[TBL] [Abstract][Full Text] [Related]
3. Pygo2 activates BRPF1 via Pygo2-H3K4me2/3 interaction to maintain malignant progression in colon cancer.
Ling J; Tang Z; Yang W; Li Y; Dong X
Exp Cell Res; 2023 Oct; 431(1):113696. PubMed ID: 37423512
[TBL] [Abstract][Full Text] [Related]
4. BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells.
Kapoor S; Damiani E; Wang S; Dharmanand R; Tripathi C; Tovar Perez JE; Dashwood WM; Rajendran P; Dashwood RH
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297001
[TBL] [Abstract][Full Text] [Related]
5. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway.
Dou C; Sun L; Wang L; Cheng J; Wu W; Zhang C; Xu Q; Tu K; Liu J
Cell Death Dis; 2020 Sep; 11(9):730. PubMed ID: 32908135
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
9. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract][Full Text] [Related]
10. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
Klein DC; Lardo SM; Hainer SJ
Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
[TBL] [Abstract][Full Text] [Related]
11. Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis.
Wang Y; Yang Y; Wang X; Jin T; Zhu G; Lin Z
J Gastroenterol Hepatol; 2021 Mar; 36(3):710-720. PubMed ID: 32710796
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
13. Methyltransferase like 3 enhances pinin mRNA stability through N
He M; Jiang D; Xun A; Yang J; Luo Q; Wu H
Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844
[TBL] [Abstract][Full Text] [Related]
14. Targeting BRD9 for Cancer Treatment: A New Strategy.
Zhu X; Liao Y; Tang L
Onco Targets Ther; 2020; 13():13191-13200. PubMed ID: 33380808
[TBL] [Abstract][Full Text] [Related]
15. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
16. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
Miao Z; Liu S; Xiao X; Li D
Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance.
Crawford TD; Vartanian S; Côté A; Bellon S; Duplessis M; Flynn EM; Hewitt M; Huang HR; Kiefer JR; Murray J; Nasveschuk CG; Pardo E; Romero FA; Sandy P; Tang Y; Taylor AM; Tsui V; Wang J; Wang S; Zawadzke L; Albrecht BK; Magnuson SR; Cochran AG; Stokoe D
Bioorg Med Chem Lett; 2017 Aug; 27(15):3534-3541. PubMed ID: 28606761
[TBL] [Abstract][Full Text] [Related]
18. TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect.
Xing Y; Luo P; Hu R; Wang D; Zhou G; Jiang J
Cancer Manag Res; 2020; 12():13195-13206. PubMed ID: 33380827
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
Dang W; Zhu Z
J Gene Med; 2020 Jul; 22(7):e3183. PubMed ID: 32159255
[TBL] [Abstract][Full Text] [Related]
20. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
Lou W; Gao K; Xu C; Li Q
IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
